Skip to content

Effects of Aromatherapy on labor: A triple blind randomized clinical trial

The use of aromatherapy in humanized labor

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-86ksrj
Enrollment
Unknown
Registered
2020-07-03
Start date
2018-12-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Contraction,labor,Aromatherapy

Interventions

The Trial was composed of three study groups: G1. Aromatherapy (n = 20)
G2 Vegetable oil without actives (n = 20) and G3. Control (n = 21). The therapy (oil application) occurred when the patient was 6 cm dilated, being evaluated for uterine dynamics, BCF auscultation and
Other
E02.190

Sponsors

universidade federal do piaui
Lead Sponsor
universidade federal do piaui
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pregnant women in active labor; of age; term pregnancy; In spontaneous labor; live fetus, fetus with cephalic apex presentation, fetus with good vitality conditions.

Exclusion criteria

Exclusion criteria: Pregnant women in latent labor; pregnant women who had an indication for cesarean delivery at admission; pregnant women who had clinical complications; pregnant women with changes in amniotic fluid and presence of fetal malformation; pregnant women in labor induction or with indication for uterotonic use.

Design outcomes

Primary

MeasureTime frame
To assess pain relief in labor, verified by the Visual Analog Scale, based on a finding of pain reduction at the scale levels.;To assess the uterine dynamics in labor, verified by palpation of the uterus for ten minutes.;To assess the time of the active phase of delivery, verified by the time of 4 cm of cervical dilation until delivery.

Secondary

MeasureTime frame
It is expected to find a decrease in the time of active phase of labor.;It is expected to find a decrease in the need to use uterotonics.

Countries

Brazil

Contacts

Public ContactBruna Reis

universidade federal do piaui

bruna_sepulvedra@hotmail.com86 994478138

Outcome results

None listed

Source: REBEC (via WHO ICTRP)